Columbia University DKV | New York Academy of Sciences | Mailman School of Public Health | NIAID
Home Feedback | About | print Print | Help
Search
Speakers
Latest Headlines
Executive Summary
Topics and Speakers
Coronavirus Biology and Pathogenesis
On the Front Lines
Approaches to Vaccines and Drug Development
Future Perspectives on Emerging Infections
Special Pathogens in Three Cultures
SARS and Public Health Systems
A View from the Field and the Bridge
Panel 4 Discussion
References and Resources
pdf Conference Transcript
pdf Conference Highlights
SARS in the Context of Emerging Infectious Threats SARS in the Context of Emerging Infectious Threats
Future Perspectives on Emerging Infections
A View from the Field and the Bridge

John La Montagne, National Institute of Allergy and Infectious Diseases, Bethesda
Play Video Read Transcript
Biography | Contact

Highlights

• SARS is an important problem because it is unpredictable and is causing dramatic impacts and disruption.
• Collaboration and cooperation amongst agencies, between the public and private sectors, and internationally are key to addressing SARS.
• NIAID is convening a meeting on May 30 to talk about research activities related to SARS; information is available at http://sars.iqsolutions.com.
• NIAID has initiated grant and contracts programs for diagnostic, vaccine, and therapeutic development against SARS.

Previous | Next
Columbia University Digital Knowledge Ventures New York Academy of Sciences Columbia University Mailman School of Public Health National Institute of Allergy and Infectious Diseases United States Department of Health & Human Services
© 2003 Columbia University | Privacy Policy.
This Web site is being provided to you for your own use.
Any copying or distribution of this Web site is prohibited.